TREA

98648435 - ONTELRIQ

Follow

Information

  • Trademark
  • 98648435
  • Serial Number
    98648435
  • Filing Date
    July 15, 2024
    2 years ago
  • Transaction Date
    May 08, 2025
    a year ago
  • Status Date
    April 29, 2025
    a year ago
  • Published for Opposition Date
    March 04, 2025
    a year ago
  • Location Date
    April 29, 2025
    a year ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    KRASS, KRISTINA
  • Attorney Docket Number
    A968-40
    Attorney Name
    Ben Natter
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ONTELRIQ
Case File Statements
  • GS0051: Pharmaceutical preparations for treating cancer, oncological diseases, rare diseases, namely, growth disorders, bone diseases, musculoskeletal diseases, namely, fibrodysplasia ossificans progressiva, connective tissue diseases, spinal cord diseases, fractures, sprains, cartilage injuries, rare chronic liver diseases and cholestatic diseases, liver diseases, respiratory diseases, cardiovascular diseases, immune disorders, namely autoimmune diseases, chronic liver diseases, gastrointestinal diseases, metabolic diseases, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia, inflammatory diseases, namely, enteric disease and connective tissue inflammation, urological diseases, disorders and diseases of the genitourinary system, namely, infertility, urovaginal infections, bladder disorders and sexually transmitted diseases, diseases and disorders of precocious puberty, gynecological disorders, to stimulate human fertility, for the treatment of acromegaly and malignant tumors, hormonal disorders, endocrine system disorders, namely, growth and thyroid gland disorders, connective tissue diseases, blood disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, namely, brain injuries, spinal cord injuries, epileptic disorders, Alzheimer's disease, Huntington's disease and cerebral palsy, musculoskeletal disorders, bone diseases, neuromuscular disorders, namely, muscular dystrophy, muscle dystonias and cervical dystonia, cerebral palsy, muscle spasticity, blepharospasm, migraine, for the treatment of pain, for the treatment of glabellar lines, facial wrinkles, for the treatment and prevention of skin diseases, facial asymmetry
Case File Event Statements
  • 7/15/2024 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/15/2024 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/31/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/17/2025 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/24/2025 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/17/2025 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/17/2025 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/24/2025 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/24/2025 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/11/2025 - a year ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/11/2025 - a year ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/11/2025 - a year ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/11/2025 - a year ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/11/2025 - a year ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/26/2025 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/4/2025 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2025 - a year ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/29/2025 - a year ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/7/2025 - a year ago
    19 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR